FDA
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Black Diamond Therapeutics (BDTX)
-
-
-
-
-
-
-
Black Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Black Diamond Therapeutics (BDTX) Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway
-
-
-
-
-
-
-
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Black Diamond Therapeutics Announces Changes to Board of Directors
-
-
-
-
-
-
-
Black Diamond Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
328,249 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

